Steven C. Gilman - 03 Jun 2022 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
Director
Signature
/s/ Carolyn Rucci, attorney-in-fact for Steven C. Gilman
Issuer symbol
AKBA
Transactions as of
03 Jun 2022
Net transactions value
-$1,653
Form type
4
Filing time
07 Jun 2022, 16:03:57 UTC
Previous filing
18 May 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale $1,653 -4,567 -9.5% $0.3620 43,430 03 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 2, 2021.